Behavioural and physiological effects induced by an infusion of antisense to α(2D)-adrenoceptors in the rat

British Journal of Pharmacology

Volumn 130, Issue 1, 2000, Pages 153-159

  Robinson, E S J ^a   Nutt, D J ^a   Jackson, H C ^b   Hudson, A L ^a  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

^b Research and Development   (United Kingdom)

Author keywords

Antisense oligonucleotides; Behavioural profile; Body temperature; Body weight; Food and water intake; Mydriasis

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ANTISENSE OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; LOCOMOTION; MALE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PUPIL; RAT; WEIGHT GAIN;

ANIMALS; BODY TEMPERATURE; DRINKING; EATING; GROOMING; MALE; MOTOR ACTIVITY; OLIGONUCLEOTIDES, ANTISENSE; PUPIL; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; WEIGHT GAIN;

EID: 0034116013     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703296     Document Type: Article

References (43)

1. 2-adrenoceptor binding and function after irreversible inactivation by n-ethoxycarbonyl-2-ethoxy-1, 2-dihydroxyquinoline (EEDQ). Eur. J. Pharmacol., 116, 175-178.
2. 2-adrenoceptor mechanism. Br. J. Pharmacol., 96, 133-143.
3. 2-agonists in reserpinized and normal mice. Br. J. Pharmacol., 96, 144-152.
4. 6 receptor in the rat brain: a study using antisense oligonucleotides. J. Pharmacol. Exp. Ther., 274, 173-180.
5. 2-adrenoceptors: pharmacology and molecular biological evidence converge. Trends Pharmacol. Sci., 9, 356-361.
6. CEDERBAUM, J.M. & AGHAJANIAN, G.K. (1977). Catecholamine receptors on locus coeruleus neurones: pharmacological characterisation. Eur. J. Pharmacol., 44, 375-385.
7. 2-receptors in the CNS: studies with mianserin. Arch. Int. Pharmacodyn. Ther., 242, 59-76.
8. CROOKE, S.T. (1992). Therapeutic application of antisense oligonucleotides. Annu. Rev. Pharmacol. Toxicol., 32, 329-376.
9. DICKINSON, S.L., GADIE, B., HAVLER, M.E., HUNTER. C. & TULLOCH, I.F. (1989). Behavioural effects of idazoxan given by continuous osmotic mini-pump in the rat. Br. J. Pharmacol., 98, 932P.
10. 2-adrenoreceptor antagonists induce behavioural activation in the rat. J. Psychopharmacol., 4, 90-99.
11. 2 sites in the mammalian central nervous system. Pharmac. Ther., 68, 175-208.
12. GÖTHERT, M. & SCHLICKER, E. (1991). Regulation of serotonin release in the central nervous system by pre-synaptic heteroreceptors. In: Presynaptic regulation of neurotransmitter release: A handbook. ed. Feigenbaum, J. & Hanani, M. pp. 845-876. Tel Aviv: Freund Publishing House.
13. 1-adrenoceptor function. Neuropharmacology, 23, 1241-1251.
14. 2D subtype. Eur. J. Pharmacol., 277, 215-221.
15. 2-adrenoceptors. Pharmacol. Biochem. Behavior., 50, 219-224.
16. HEY, J.A., GHEREZGHIHER, T. & KOSS, M.C. (1985). Studies on the mechanism of clonidine-induced mydriasis in the rat. Naunyn Schmiedebergs Arch. Pharmacol., 328, 258-263.
17. 2-adrenoceptor subtypes to the antinociceptive action of dexmetetomidine and clonidine in rodent models of acute and chronic pain. Br. J. Pharmacol., 120 (Suppl.): 220P.
18. 2-adrenoceptor antagonists on food and water intake in the rat. Br. J. Pharmacol., 104, 258-262.
19. KOCH, G.G. & EDWARDS, S. (1988). Clinical efficacy trials with categorical data. In: Biopharmaceutical statistics for drug development. ed. Peace, K.E. pp. 418-421. New York: Marcel Dekker.
20. 2-adrenoceptor activation. J. Pharmacol. Methods, 15, 1-19.
21. LANGER, S.Z. (1997). 25 Years since the discovery of presynaptic receptors: Present knowledge and future perspectives. Trends Pharmacol. Sci., 18, 95-99.
22. LE CORRE, S.M., BURNET, P.W.J., MELLER, R., SHARP, T. & HARRISON, P.J. (1997). Critical issues in the antisense inhibition of brain geneexpression in vivo:Experiences targetting the 5-HT(1A) receptor. Neurochem. Int., 31, 349-362.
23. 2D-autoreceptors in mouse brain. Naunyn Schmiedebergs Arch. Pharmacol., 352, 43-48.
24. LIN, M.T., JOU, J.J. & KO, W.C. (1981). Effects of intracerebroventricular injection of clonidine on metabolic respiratory, vasomotor and temperature responses in the rabbit. Naunyn Schmiedebergs Arch. Pharmacol., 87, 195-201.
25. 2-Adrenoceptors: more subtypes but fewer functional differences. Trends Pharmacol. Sci., 15, 119-123.
26. alpha-2A adrenergic receptors in the control of nociception, motor behaviour and hippocampal synthesis of noradrenaline. J. Pharmacol. Exp. Ther., 270, 958-972.
27. 2A-adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat. J. Clin. Invest., 98, 1076-1080.
28. 2-adrenoceptors and blood pressure regulation in the rat. Eur. J. Pharmacol., 278, 183-185.
29. 2-adrenoceptor antagonists on extracellular dopamine concentrations in rat striatum. In: Noradrenergic mechanisms in Parkinson's Disease. ed. Briley, M. & Marien, M. pp. 159-172. Boca Raton: CRC Press.
30. NUTT, D.J., LALIES, M.D., LIONE, L.A. & HUDSON, A.L. (1997). Noradrenergic mechanisms in the prefrontal cortex. J. Psychopharmacol., 11, 163-168.
31. PAXINOS, G. & WATSON, C. (1986). The rat brain in stereotaxic coordinates, New York: Academic Press.
32. 2 dopamine receptors. Mol. Pharmacol., 48, 730-737.
33. REINSTEIN, D.K. & ISSACSON, R.L. (1977). Clonidine sensitivity in the developing rat. Brain Res., 135, 378-382.
34. alpha-2A adrenergic receptors and other populations of alpha-2 adrenergic subtypes. J. Pharmacol. Exp. Ther., 270, 946-957.
35. 2D-adrenoceptor in the rat. Br. J. Pharmacol., 128, 515-522.
36. ROBINSON, E.S.J., NUTT, D.J., JACKSON, H.C. & HUDSON, A.L. (1997). Antisense oligonucleotides in psychopharmacology and behaviour: promises and pitfalls. J. Psychpharmacol., 11, 259-269.
37. SCHLINGENSIEPEN, K.-H. & HEILIG, M. (1997). Gene function analysis and therapeutic prospects in neurobiology. In: Antisense - from technology to therapy. Lab manual and textbook. ed. Schlingensiepen, R., Brysch, W. & Schlingensiepen, K.-H. pp. 186-223. Vienna: Blackwell Science Ltd.
38. TRENDELENBURG, A.U., LIMBERGER, N. & STARKE, K. (1993). Presynaptic alpha 2-autoreceptors in brain cortex: alpha 2D in the rat and alpha 2A in the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 35-45.
39. 2-agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacological effects of clonidine and related adrenergic agents. Brain Res. Rev., 7, 69-101.
40. 1 dopamine receptor agonist SKF38393 in the rat. Psychopharmacology, 109, 41-48.
41. WEISS, B., DAVIDKOVA, G. & ZHANG, S.-P. (1997). Antisense strategies in neurobiology. Neurochem. Int., 31, 321-348.
42. XU, K., NAVERI, L., FRERICHS, K.U., HALLENBECK, J.M., FEUERSTEIN, G., DAVIS, J.N. & SIREN, A.L. (1993). Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals. J. Pharmacol. Exp. Ther., 267, 211-217.
43. YAIDA, Y. & NOWAK, T.S. (1995). Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridisation. Reg. Peptides, 59, 193-199.